Last November, in Lisbon, we attended #PEGSEUROPE , the 15th Annual Protein & Antibody Engineering Summit and one of the most renowned conferences in the field.
BioClonal had the opportunity to explain scientific advances with the posters presentations:
➡ A003: Rational Antibody Discovery: Novel Target for Alzheimer Disease Reachable with RedMabs, presented by our Chief Executive Officer Paula Garfella
➡ B025: Disruptive In Vivo Antibody Discovery, presented by our Chief Research & Development Officer, Jessika Valero.
We want to thank all the interest that our company has awakened in the sector, the great reception of our results and all the new contacts we have been able to make.
Looking forward to the next edition!